Companies: 10,639     total market cap: โ‚น12257.312 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alnylam Pharmaceuticals
ALNY
#433
Rank
โ‚น4.826 T
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น36,534
Share price
-2.59%
Change (1 day)
69.53%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น21.12 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has โ‚น21.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น5.75 B-131.33%
2023-12-31$-โ‚น18.37 Billion40.29%
2022-12-31$-โ‚น13.1 Billion-129.91%
2021-12-31$โ‚น43.78 B-41.09%
2020-12-31$โ‚น74.32 B-27.56%
2019-12-31$โ‚น102.59 B12.7%
2018-12-31$โ‚น91.03 B-19.29%
2017-12-31$โ‚น112.78 B80.36%
2016-12-31$โ‚น62.53 B-25.6%
2015-12-31$โ‚น84.04 B41.64%
2014-12-31$โ‚น59.33 B255.28%
2013-12-31$โ‚น16.70 B127.55%
2012-12-31$โ‚น7.33 B17.59%
2011-12-31$โ‚น6.24 B-11.97%
2010-12-31$โ‚น7.09 B-14.13%
2009-12-31$โ‚น8.25 B-15%
2008-12-31$โ‚น9.71 B24.29%
2007-12-31$โ‚น7.81 B-12.27%
2006-12-31$โ‚น8.90 B220.5%
2005-12-31$โ‚น2.78 B39.12%
2004-12-31$โ‚น1.99 B-264.34%
2003-12-31$-โ‚น1.22 Billion445.78%
2002-12-31$-โ‚น0.23 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Arrowhead Pharmaceuticals
ARWR
โ‚น46.95 B 122.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น2.796 T 13,135.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น119.24 B 464.41%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น117.92 B 458.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น6.23 B-70.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น4.042 T 19,033.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น7.794 T 36,795.86%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚น655.23 B 3,001.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com